Gene · 286
ANK1: ankyrin 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ANK1: ankyrin 1. Genes, record 286. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/286
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P16157 | Ankyrin-1 | 1,881 | 21 | Ensembl, GeneID, HGNC |
Source UniProt
Patents30
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 37409 | P16157 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 6202 | P16157 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 835 | P16157 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 5485 | P16157 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 5485 | P16157 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 6202 | P16157 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 4853 | P16157 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 835 | P16157 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 835 | P16157 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 842 | P16157 | Espacenet |
1 to 10 of 30
See all 30 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,147
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ANK1 papers | Newest fiscal year |
|---|---|---|---|
| R01DK093757 | Genetic epidemiology of rare and regulatory variants for metabolic traits | 10 | 2025 |
| ZIABC007365 | Regulation of ADP-ribosylation factor | 10 | 2025 |
| R01DK062370 | Identifying Genes for Type 2 Diabetes: FUSION | 7 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| P30DK020572 | Michigan Diabetes Research Center (MDRC) | 6 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 5 | 2025 |
| R01HL086694 | From GWAS loci to blood pressure genes, variants & mechanisms - Renewal | 5 | 2025 |
| T32AR007592 | Interdisciplinary Training Program in Muscle Biology | 5 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 5 | 2025 |
| ZIAHG000024 | Genetic analysis of type II diabetes | 5 | 2025 |
1 to 10 of 2,147Source NIH's project files
See all 2,147 nih grantsPapers2,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of a shared blood-brain transcriptomic signature in Parkinson's disease using bioinformatic and network pharmacology approaches. | Neuroscience | 2026 | 42826760 | PubTator, text mining | PubMed |
| Clinical characteristics, genotype-phenotype correlation, and prognostic follow-up of 48 Chinese children with hereditary spherocytosis. | Front Med (Lausanne) | 2026 | 42819045 | PubTator, text mining | PubMed |
| Molecular Distinctions, Diagnosis, and Mechanism-Based Therapies in Lipedema and Obesity. | Curr Issues Mol Biol | 2026 | 42793248 | PubTator, text mining | PubMed |
| Capsaicin and cinnamaldehyde as topical transient receptor potential vanilloid 1 and transient receptor potential ankyrin 1 agonists in humans: Formulation, stability, and pharmacodynamic evaluation. | J Pharmacol Exp Ther | 2026 | 42772018 | PubTator, text mining | PubMed |
| Regulation of transient receptor potential ankyrin-1 agonist-induced airway epithelial cell injury and repair by protein kinase C and p38 mitogen-activated kinase. | Mol Pharmacol | 2026 | 42759295 | PubTator, text mining | PubMed |
| Pharmacological readthrough and base editing for ANK1 nonsense mutations in an erythroid model of hereditary spherocytosis. | Mol Ther Nucleic Acids | 2026 | 42667096 | PubTator, text mining | PubMed |
| miR-486-5p suppresses autophagy in hepatocellular carcinoma via activation of the AKT/mTOR signalling pathway. | Mol Biomed | 2026 | 42635933 | PubTator, text mining | PubMed |
| Novel 1,3,5-triazine-based TRPA1 activators alleviate pro-fibrotic response in human lung fibroblasts. | Eur J Pharmacol | 2026 | 42601007 | PubTator, text mining | PubMed |
| Alzheimer's Disease DNA Methylation Index (AD-DMI) and its Association with Late-Life Cognitive Function. | NPJ Dement | 2026 | 42583477 | PubTator, text mining | PubMed |
| Case Report: A research on a case of hereditary spherocytosis with idiopathic pulmonary hemosiderosis. | Front Pediatr | 2026 | 42558654 | PubTator, text mining | PubMed |
1 to 10 of 2,731
See all 2,731 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/286
GET https://conductscience.org/api/genes/v1/286/patents?page=2